AbCellera Biologics (ABCL) news
Recent news
CCI: Commission OKs purchase of majority stake in Tribhovandas Bhimji Zaveri Limited by GRT Jewelers (India) Private Limited
The Competition Commission of India (CCI) has approved the acquisition of a majority stake in Tribhovandas Bhimji Zaveri Limited (TBZL) by GRT Jewelers (India) Private Limited. The transaction, which involves GRT Jewelers acquiring a controlling interest in TBZL, has cleared regulatory scrutiny and…
AInvest Wire · 2d agoABCellera Biologics Inc.: JP Morgan initiates coverage with overweight rating; target price $17
JP Morgan has initiated coverage on AbCellera Biologics Inc. (ABCL) with an overweight rating and a target price of $17 per share, reflecting optimism around the company’s clinical progress and strategic partnerships. This aligns with recent analyst commentary that has raised the fair value…
AInvest Wire · Sep 29, 2026AbCellera prices offering of 17.4M shares at $9.75 each
AInvest Wire · Aug 13, 2026Abcellera Biologics shares down 5.3% after launching $200 mln stock offering
AInvest Wire · Aug 12, 2026Shares of Abcellera Biologics down 7.9% premarket after launching $200 mln stock offering
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) fell 7.9% in premarket trading on August 12, 2026, following the company’s announcement of a $200 million underwritten public offering of common stock and pre-funded warrants. The offering, led by Jefferies, J.P. Morgan, Cantor Fitzgerald, UBS…
AInvest Wire · Aug 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.